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was markedly reduced compared with
isozyme A of normal mucosa. Heating of
enzyme extracts at 50°C for 30 min before
electrophoresis caused no change in the
electrophoretic mobilities of any of the
isozymes but slightly reduced their staining
intensities. On the other hand, after heating
at 55°C for 30 min, isozymes A and C were
hardly detectable on subsequent staining.
Incubation of enzyme extracts with neura-
minidase at 37°C for 18 h caused no signi-
ficant changes either in the mobility or in the
staining reaction of any of these isozymes
from normal and experimental tissuse.
Isozymes A and C appeared to be soluble
enzymes whereas isozyme B, due to its
extraction in 0.2% Triton X-100, seemed to
be bound to lysosomes.
IS ALKYLATION OF NICOTINAMIDE
THE CAUSE OF LIVER NECROSIS
THAT FOLLOWS LARGE DOSES OF
HEPATOCARCINOGENS? R. SCHOEN-
TAL, Department of Pathology, Royal
Veterinary College, London.
Large doses of hepatocarcinogens cause
liver necrosis, not seen after doses which can
induce tumours. In the course of their
metabolism, many hepatocarcinogens yield
alkylating entities, known to alkylate nucleic
acids, proteins and other cell constituents,
including nicotinamide (Schein etal., Biochem.
Pharmac., 1973, 22, 2625; Chu and Lawley,
Chem. Biol. Interactions, 1974, 8, 65).
Alkylated derivatives of nicotinamide cannot
be utilized for the biosynthesis of NAD
cofactors, essential for cell survival. Deple-
tion ofNAD in the liver occurs after pyrrolizi-
dine alkaloids, dimethylnitrosamine, strepto-
zotocin etc., and can be prevented by
pretreatment with nicotinamide, which in
some cases prevents also the cytotoxic
effects.
More information is needed as regards the
role of alkylated derivatives of nicotinamide
in cell death and in relation to tumour
induction.
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CHEMICAL BASIS FOR THE
RELATIONSHIP BETWEEN MUTA-
GENESIS AND CARCINOGENESIS.
P. BROOKES, Pollards Wood Research
Station, Bucks.
A relationship between carcinogenesis and
mutagenesis was first suggested by T. Boveri
in 1917 and K. H. Bauer in 1928 proposed the
somatic mutation theory of cancer, although
at that time the nature ofthe genetic material
was unknown. The recognition of the
biological role of DNA, following the elucid-
ation of its structure by Crick and Watson in
1953, did not immediately revive the support
for the mutation theory of cancer which had
been under strong attack. This was mainly
the result of the repeated failure to demon-
strate mutation with such classic carcinogens
as the polycyclic hydrocarbons and aromatic
amines. Prior to 1940 polycyclic hydro-
carbons were almost the only well studied
group ofcarcinogens. During the subsequent
20 years, however, the number and variety of
chemical substances both synthetic and
naturally occurring, which were shown to
induce cancer in animals, became so great
that it seemed impossible to conceive of any
common mechanism of tumour induction.
The breakthrough came with the recog-
nition of the importance of metabolism in
converting the applied carcinogen to the
biologically active form. One class of car-
cinogen, namely the biological alkylating
agents, did not require metabolic activation
and a study oftheir mechanism of action had
implicated DNA reaction. It seemed
possible therefore that all carcinogens might
act via electrophilic intermediates similar to
those involved in alkylation and that these
" ultimate carcinogens" might modify
cellular DNA.
A great deal of evidence is now available
which supports both the above postulates.
In the case of the aromatic amines the
identification of N-hydroxy metabolites by
the Millers led to an understanding of